Cargando…

Multiple sclerosis relapses not associated with mRNA COVID-19 vaccine

Detalles Bibliográficos
Autor principal:	Fyfe, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412380/ https://www.ncbi.nlm.nih.gov/pubmed/34475567 http://dx.doi.org/10.1038/s41582-021-00561-1

Ejemplares similares

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients
por: Hammer, Helly, et al.
Publicado: (2022)

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
por: Quintanilla-Bordás, Carlos, et al.
Publicado: (2022)

Osteopontin Is Associated with Multiple Sclerosis Relapses
por: Stampanoni Bassi, Mario, et al.
Publicado: (2023)

New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
por: Toljan, Karlo, et al.
Publicado: (2022)

Fight against COVID-19 with mRNA vaccines and interaction with Dermal fillers
por: Ghasemi, Shohreh, et al.
Publicado: (2021)

Severe rhabdomyolysis secondary to COVID-19 mRNA vaccine in a teenager
por: Pucchio, Aidan, et al.
Publicado: (2022)

COVID-19 database launched in the USA
por: Fyfe, Ian
Publicado: (2021)

Relapsed Disciform Stromal Herpetic Keratitis and mRNA COVID-19 Vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Is the mRNA COVID-19 Vaccine Safe in Patients With a Prior History of Myocarditis?
por: Shahid, Rida, et al.
Publicado: (2023)

Relapse of Immune Thrombotic Thrombocytopenic Purpura Following Vaccination with COVID19 mRNA Vaccine
por: Pavenski, Katerina
Publicado: (2021)

Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine
por: Tuschen, Katharina, et al.
Publicado: (2021)

Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs
por: Mazziotti, Valentina, et al.
Publicado: (2022)

Absence of Antibody Reponses and Severe COVID-19 in Patients on Hemodialysis Following mRNA Vaccination
por: Michael, Miriam B, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers
por: Knobel, Pablo, et al.
Publicado: (2021)

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines
por: Qasim, Hana, et al.
Publicado: (2023)

Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine
por: Sandu, Georgiana C., et al.
Publicado: (2023)

Rhabdomyolysis after BNT162b2 mRNA Covid-19 vaccine in an adolescent male
por: Sutcu, Murat, et al.
Publicado: (2022)

CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study
por: Svačina, Martin K. R., et al.
Publicado: (2023)

Covid-19-vaccine: Relapse of multiple sclerosis: case report
Publicado: (2022)

Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine
por: Dominelli, Federica, et al.
Publicado: (2022)

mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis
por: Blanco, Yolanda, et al.
Publicado: (2023)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

Investigating two versus three doses of mRNA vaccine in patients with cirrhosis
por: Hindson, Jordan
Publicado: (2022)

BMI-Associated Anti-Apolipoprotein A-1 Positivity in Healthy Adults after mRNA-Vaccination against COVID-19
por: Máčalík, Roman, et al.
Publicado: (2023)

Associations among stressors across the lifespan, disability, and relapses in adults with multiple sclerosis
por: Polick, Carri S., et al.
Publicado: (2023)

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021)

Immune Thrombocytopenia Purpura Relapse in Patients Who Received mRNA COVID-19 Vaccines
por: Qasim, Hana, et al.
Publicado: (2022)

Immune Thrombocytopenia Relapse in Patients Who Received mRNA COVID-19 Vaccines [Letter]
por: Ali, Anumta, et al.
Publicado: (2023)

COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021)

COVID-19 mRNA Vaccination
por: Vered, Livneh, et al.
Publicado: (2022)

Humoral and Cellular Response after mRNA Vaccination in Nursing Homes: Influence of Age and of History of COVID-19
por: San Román, Jesús, et al.
Publicado: (2022)

Myocarditis Associated with mRNA COVID-19 Vaccination
por: Starekova, Jitka, et al.
Publicado: (2021)

COVID-19 mRNA Vaccine-Associated Myocarditis
por: Kyaw, Htin, et al.
Publicado: (2022)

Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent
por: Minocha, Prashant K., et al.
Publicado: (2021)

Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy
por: Faruk, Turan Ömer, et al.
Publicado: (2022)

Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy
por: Rico, Audrey, et al.
Publicado: (2021)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
por: Capone, Fioravante, et al.
Publicado: (2021)

Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience()
por: Bertozzi, Andrea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iirfjavs4t53meiksbi2bfj18f